Balyasny Asset Management
AUXL

Balyasny Asset Management’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Balyasny Asset Management’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-165,000
Closed -$3.31M – 969
2014
Q2 		$3.31M Buy
+165,000
New +$3.78M 0.04% 464
2013
Q3 		– Sell
-167,623
Closed -$2.79M – 809
2013
Q2 		$2.79M Buy
+167,623
New +$2.68M 0.05% 406

Other funds holding AUXL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Balyasny Asset Management's AUXL Position: Q3 2014 in Review

Balyasny Asset Management sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2014, closing a stake of 165,000 shares — an estimated $3.31M sold.

Balyasny Asset Management first reported a position in AUXL in Q2 2013 and held it in 2 quarters. The position peaked at $3.31M in Q2 2014. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2014.

  • Balyasny Asset Management reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Balyasny Asset Management sold 165,000 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2014, an estimated $3.31M.
  • Balyasny Asset Management first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Balyasny Asset Management's AUXILIUM PHARAMCEUTICALS INC position peaked at $3.31M in Q2 2014.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2014.

Based on Balyasny Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.